PMU47 ORPHAN DRUG DESIGNATION: NO IMPACT ON PR PROCESS TIMING IN ITALY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1666
https://www.valueinhealthjournal.com/article/S1098-3015(19)34044-6/fulltext
Title :
PMU47 ORPHAN DRUG DESIGNATION: NO IMPACT ON PR PROCESS TIMING IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34044-6&doi=10.1016/j.jval.2019.09.1666
First page :
Section Title :
Open access? :
No
Section Order :
11445